Victor Serebrov

Victor Serebrov has a diverse work experience in the field of biochemistry and pharmacology. Victor currently serves as the Director at Entact Bio since September 2022. Prior to that, they worked as a Senior Principal Scientist at Korro Bio, Inc. from March 2021 to December 2022. Before joining Korro Bio, Inc., Victor held the position of Associate Principal Scientist, Pharmacology at Merck from April 2017 to March 2021. Victor also served as an Instructor at the University of Massachusetts Medical School from July 2009 to April 2017. Victor began their career as a Postdoctoral Scientist at Yale University School of Medicine from 2002 to 2009 and as a Postdoctoral Researcher at Columbia University in the City of New York from 2001 to 2002.

Victor Serebrov earned a Master's Degree in Chemistry from Lomonosov Moscow State University (MSU) from 1990 to 1995. Victor then pursued further education at the Engelhardt Institute of Molecular Biology from 1996 to 2001, where they obtained their Doctor of Philosophy (Ph.D.) in Biochemistry.